Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in the First Three Months After Mitral or Aortic Biological Valve Replacement or Repair

NCT07434661 is registered in ClinicalTrials.gov with Meshalkin Research Institute of Pathology of Circulation as lead sponsor.

NCT NCT07434661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07434661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in the First Three Months After Mitral or Aortic Biological Valve Replacement or Repair
Lead sponsor
Meshalkin Research Institute of Pathology of Circulation
Phase
Phase 3
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
January 31, 2029
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve surgery, atrial fibrillation (af), mitral valve annuloplasty, mitral valve repair, mitral valve surgery, valve disease, heart, valve replacement surgery